Nrgene Technologies Ltd (NRGN) - Total Liabilities
Based on the latest financial reports, Nrgene Technologies Ltd (NRGN) has total liabilities worth ILA5.12 Million ILA (≈ $13.74K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Nrgene Technologies Ltd to track the company's year-over-year net asset growth rate.
Nrgene Technologies Ltd - Total Liabilities Trend (2018–2025)
This chart illustrates how Nrgene Technologies Ltd's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Nrgene Technologies Ltd to measure how efficiently the company converts operating cash flow to free cash.
Nrgene Technologies Ltd Competitors by Total Liabilities
The table below lists competitors of Nrgene Technologies Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hwa Tai Industries Bhd
KLSE:8478
|
Malaysia | RM73.95 Million |
|
Academies Australasia Group Ltd
AU:AKG
|
Australia | AU$54.87 Million |
|
JLEN Environmental Assets Group Ltd
LSE:JLEN
|
UK | GBX1.95 Million |
|
Golden Deeps Ltd
AU:GED
|
Australia | AU$301.13K |
|
FD Technologies Plc
LSE:FDP
|
UK | GBX149.47 Million |
|
Tapaco Public Company Limited
BK:TAPAC
|
Thailand | ฿942.67 Million |
|
Alta S.A.
WAR:AAT
|
Poland | zł5.42 Million |
|
Heart Test Laboratories Inc. Common Stock
NASDAQ:HSCS
|
USA | $1.81 Million |
Liability Composition Analysis (2018–2025)
This chart breaks down Nrgene Technologies Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Nrgene Technologies Ltd (NRGN) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.23 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.19 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.54 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nrgene Technologies Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nrgene Technologies Ltd (2018–2025)
The table below shows the annual total liabilities of Nrgene Technologies Ltd from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ILA5.12 Million ≈ $13.74K |
+156.89% |
| 2024-12-31 | ILA2.00 Million ≈ $5.35K |
-44.16% |
| 2023-12-31 | ILA3.57 Million ≈ $9.58K |
-29.18% |
| 2022-12-31 | ILA5.04 Million ≈ $13.53K |
-41.90% |
| 2021-12-31 | ILA8.68 Million ≈ $23.28K |
-6.88% |
| 2020-12-31 | ILA9.33 Million ≈ $25.00K |
+17.66% |
| 2019-12-31 | ILA7.93 Million ≈ $21.25K |
+31.95% |
| 2018-12-31 | ILA6.01 Million ≈ $16.10K |
-- |
About Nrgene Technologies Ltd
NRGene Technologies Ltd operates as a research and development company focusing on intellectual property-intensive technological products in the field of AgTech in North America, Europe, the Middle East, Africa, Asia Pacific, and internationally. It develops and commercializes plant varieties, traits, and animals based on artificial intelligence (AI) technology and software tools for analyzing ge… Read more